HQ: South Plainfield, New Jersey, United States

PTC Therapeutics Contact Information – Key Personnel, Emails & Support Lines

ptcbio.com

About PTC Therapeutics Company

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

PTC Therapeutics Specialization

Biotechnology, Healthcare & Medical, Hospitals & Clinics

PTC Therapeutics General Information

HQ: South Plainfield, New Jersey, United States

Business Type: Public

Employees: 1001-5000

Rounds: Post-IPO Equity

Founded Date: 1998

Number of Exits: 1

Company Type: For Profit

Stock Symbol: NASDAQ:PTCT

Operating Status: Active

Last Funding Type: Post-IPO Equity

Phone Number: 9082227231

Last Investment Activity: Mar 19, 2024

Investments Activity: Mar 19, 2024 Mar 19, 2024 Feb 29, 2024

PTC Therapeutics Email Format

{first_letter_first_name}{last_name}@ptcbio.com — 66.7% (example: ssmith@domain.com)

{first_name}.{last_name}@ptcbio.com — 16.7% (example: sarah.smith@domain.com)

{first_name}{last_name}@ptcbio.com — 16.7% (example: sarahsmith@domain.com)

PTC Therapeutics General PTC Therapeutics Emails

  • General Inquiries

    info@ptcbio.com

  • Unclassified inbox

    Info.Nordic@ptcbio.com

  • Unclassified inbox

    pharmacovigilance@ptcbio.com

  • General Inquiries

    usmedinfo@ptcbio.com

  • Unclassified inbox

    wbaird@ptcbio.com

  • Unclassified inbox

    jbreslin@ptcbio.com

Contact details of 10 PTC Therapeutics executives

Peter P. Giannousis

Vice President Technical Operations
  • Work email

    p*********s@ptcbio.com

Paul Cosenza

Associate Director Global Commercial Learning
  • Work email

    p******a@ptcbio.com

Brett Billmeyer

Associate Director, U.S. Patient Engagement
  • Work email

    b********r@ptcbio.com

Neha Shah

Associate Director Quality Assurance
  • Work email

    n*******h@ptcbio.com

Kylie O'Keefe

Senior Vice President, Head of Global Commercial and Corporate Strategy

Stuart Peltz

Founder

Dhaval Patel

Senior Director & Head, Formulation Development

Eric Pauwels

Chief Business Officer

Neil Almstead

Executive Vice President Research, Pharmaceutical Operations and Technology

Allan Jacobson

Founder

Contact details of 5 PTC Therapeutics other employees

Lynne Messner

Market Development Manager -- Gene Therapy
  • Work email

    l******r@ptcbio.com

Tasha Alex

Manager, Clinical Supplies Planning
  • Work email

    t***x@ptcbio.com

Ludovic Baillon

Investment Analyst
  • Work email

    l************n@ptcbio.com

Mary Frances Harmon

Senior VP, Corporate Relations

Mary Ann Johnston

VP, Global Project Lead

Similar Companies like PTC Therapeutics

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics Medical Devices Hospitals & Clinics

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.